Cargando…

Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice

BACKGROUND: Wu-Mei-Wan (WMW) is a traditional Chinese herbal formulation that is clinically prescribed to treat diabetes mellitus in China. WMW has been shown to alleviate damage in pancreatic β cells, but the underlying mechanism remains unclear. This study aims to explore how WMW plays a protectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xueping, Lu, Fuer, Li, Lingli, Li, Jingbin, Luo, Jinlong, Zhang, Siyi, Liu, Xinqiao, Chen, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357370/ https://www.ncbi.nlm.nih.gov/pubmed/30704457 http://dx.doi.org/10.1186/s12906-019-2443-6

Ejemplares similares

Wu-Mei-Wan Reduces Insulin Resistance via Inhibition of NLRP3 Inflammasome Activation in HepG2 Cells
por: Yang, Xueping, et al.
Publicado: (2017)

Wu-Mei-Wan Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization
por: Yan, Shuguang, et al.
Publicado: (2022)

Traditional herbal formula Wu-Mei-Wan alleviates TNBS-induced colitis in mice by inhibiting necroptosis through increasing RIPK3 O-GlcNAcylation
por: Wu, Fan, et al.
Publicado: (2021)

Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving β cell function and reducing insulin resistance in diabetic rats
por: Chen, Guang, et al.
Publicado: (2017)

The trigger for pancreatic disease: NLRP3 inflammasome
por: Liu, Tianming, et al.
Publicado: (2023)

The Role of Berberine in the Prevention of HIF-1α Activation to Alleviate Adipose Tissue Fibrosis in High-Fat-Diet-Induced Obese Mice
por: Hu, Meilin, et al.
Publicado: (2018)

NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis
por: Ferrero-Andrés, Ana, et al.
Publicado: (2020)

Jiao Tai Wan Attenuates Hepatic Lipid Accumulation in Type 2 Diabetes Mellitus
por: Huang, Zhaoyi, et al.
Publicado: (2013)

Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome
por: Zhong, Xiaoli, et al.
Publicado: (2020)

IKKβ is required for the formation of the NLRP3 inflammasome
por: Nanda, Sambit K, et al.
Publicado: (2021)

Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage
por: Kong, Xiang, et al.
Publicado: (2017)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway
por: Li, Honglian, et al.
Publicado: (2020)

Structural insights reveal the specific recognition of meiRNA by the Mei2 protein
por: Shen, Siyuan, et al.
Publicado: (2022)

NLRP3 Inflammasome and Host Protection against Bacterial Infection
por: Kim, Jwa-Jin, et al.
Publicado: (2013)

The NLRP3 Inflammasome Is Required for Protection Against Pseudomonas Keratitis
por: Ramadan, Abdulraouf, et al.
Publicado: (2023)

NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
por: Sita, Giulia, et al.
Publicado: (2021)

Scutellarin Suppresses NLRP3 Inflammasome Activation in Macrophages and Protects Mice against Bacterial Sepsis
por: Liu, Yi, et al.
Publicado: (2018)

NLRP3 Inflammasome is Activated in Rat Pancreatic Islets by Transplantation and Hypoxia
por: Lavallard, Vanessa, et al.
Publicado: (2020)

Mei : per flauto solo (1962)
por: Fukushima, Kazuo
Publicado: (1966)

MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
por: Guan, Lei, et al.
Publicado: (2019)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Hu-Lu-Ba-Wan Attenuates Diabetic Nephropathy in Type 2 Diabetic Rats through PKC-α/NADPH Oxidase Signaling Pathway
por: Zhou, Lishan, et al.
Publicado: (2013)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
por: Shen, Yao, et al.
Publicado: (2022)

The latest breakthrough on NLRP6 inflammasome
por: Li, Runzhi, et al.
Publicado: (2022)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
por: Correa, Victor S. M. C., et al.
Publicado: (2023)

Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase
por: Shi, Wei, et al.
Publicado: (2023)

NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
por: Wang, Zhilei, et al.
Publicado: (2022)

The effect and mechanism of Jiao-tai-wan in the treatment of diabetes mellitus with depression based on network pharmacology and experimental analysis
por: Tang, Yueheng, et al.
Publicado: (2021)

Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90
por: Xu, Guang, et al.
Publicado: (2021)

Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes
por: Lv, Zhen-Huan, et al.
Publicado: (2017)

Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation
por: Hu, Jiaxin, et al.
Publicado: (2023)

Tecnologías wan /
por: Alvarez Elias, Mirna
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_60j0ag64a7chedn2faitkvrou5